Médecins Sans Frontières continues to work to improve the quality and availability of treatment for tuberculosis (TB).
Uzbekistan is one of many countries in Central Asia with high levels of drug-resistant TB (DR-TB), a form of the disease that does not respond to the standard first-line drug regimen. Access to diagnosis and good-quality care is still limited and the vast majority of people with DR-TB remain undiagnosed and untreated.
Médecins Sans Frontières believes that introducing new approaches to diagnosis and treatment of TB – such as ambulatory care, rapid diagnostic tests and a comprehensive patient support programme including education, psychological support, transportation, food packages and financial aid – will help increase adherence to treatment and control the spread of the disease.
TB programme in Karakalpakstan
In the Autonomous Republic of Karakalpakstan, Médecins Sans Frontières runs a TB programme in collaboration with the Ministry of Health, helping patients manage the side effects of their drugs and providing psychosocial support to improve treatment adherence. In 2014, over 2,000 patients were enrolled for first-line TB treatment and 607 for DR-TB. Many patients underwent treatment on an outpatient basis, so they avoided the additional stress of hospitalisation. During 2014, Médecins Sans Frontières continued to enrol multidrug-resistant TB patients on a short, nine month regimen instead of the usual two years. The first people who started the regimen in 2013 finished their treatment, and Médecins Sans Frontières will continue to monitor them for 12 months to check that the TB does not return.
Treating HIV in Tashkent
Médecins Sans Frontières is also seeking to address the developing HIV epidemic in Tashkent, Uzbekistan’s capital city. Teams continued to work at the Tashkent City AIDS Centre, and a total of 671 people were started on antiretroviral treatment. Psychosocial activities such as counselling were also provided.
Médecins Sans Frontières first worked in the country in: 1997
No. staff: 184
This text is an excerpt from the 2014 International Activity Report.
Tetyana Pylypenko is from Ukraine and has been working with Médecins Sans Frontières for over 10 years in her home country and abroad. She comes from a nursing background, and recently held the position of Medical Team Leader in...
An eye-opening account of the devastating effects of multidrug-resistant tuberculosis from Médecins Sans Frontières' Dr Jay Achar.
Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to combat this deadlier form of the disease, the...
25 wounded, two dead, at a hospital in Osh on Monday 21 June
Interview with Alexandre Baillat, Médecins Sans Frontières Head of Mission in Kyrgyzstan.
Bishkek/Tashkent, June 15th, 2010. The violent clashes that plunged the South of Kyrgyzstan into chaos since 10 June have led to an acute humanitarian crisis, with hundreds of people wounded and large displacements of population....
In Karakalpakstan, a semi-autonomous region of Uzbekistan, Medecins Sans Frontieres has been running a project treating multi-drug resistant tuberculosis (MDR-TB) since 2003. MDR-TB is a debilitating disease and requires lengthy...